Cargando…
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
The gut microbiota plays critical roles in development of obese-related metabolic diseases such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes(T2D), and insulin resistance(IR), highlighting the potential of gut microbiota-targeted therapies in these diseases. There are various ways tha...
Autores principales: | Ma, Junli, Zhou, Qihang, Li, Houkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691740/ https://www.ncbi.nlm.nih.gov/pubmed/29035308 http://dx.doi.org/10.3390/nu9101124 |
Ejemplares similares
-
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
por: He, Xuyun, et al.
Publicado: (2016) -
Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
por: Park, Eunju, et al.
Publicado: (2021) -
The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018) -
Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013) -
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)